Horizon Pharma Obtains $49,500,000 New Round

  • Feed Type
  • Date
    7/27/2011
  • Company Name
    Horizon Pharma
  • Mailing Address
    1033 Skokie Boulevard Northbrook, IL 60062
  • Company Description
    Horizon Pharma, Inc. (NASDAQ: HZNP) is a biopharmaceutical company focused on the rapid development and commercialization of therapeutic treatments for mild-to-moderate pain management. The Company is building a novel portfolio of therapies through innovative combinations of approved pharmaceutical products that seek to improve safety, efficacy, and patient compliance.
  • Website
    http://www.horizonpharma.com
  • Transaction Type
    IPO
  • Transaction Amount
    $49,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

Trending on Xconomy